This inventor holds 1 USPTO granted patent. Top assignees: 302 Hospital of Pla, China, Chinese Academy of Sciences, Tianjin Institute of Pharmaceutical Research. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015
Title: Zegui Cai: Innovator in Pharmaceutical Chemistry
Introduction
Zegui Cai is a notable inventor based in Guiyang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that can be used to treat viral infections. His work is characterized by a focus on minimizing toxic side effects while maximizing therapeutic efficacy.
Latest Patents
Zegui Cai holds a patent for "Phenylalanine dipeptide derivatives, compositions and use thereof." This patent discloses a compound of formula I, along with its stereoisomers, pharmaceutically acceptable salts, or hydrates. The pharmaceutical composition derived from this compound can be utilized to prepare a medicament aimed at treating viral infections, specifically hepatitis B virus and human immunodeficiency virus, with minimal toxic side effects.
Career Highlights
Throughout his career, Zegui Cai has worked with esteemed institutions such as the 302 Hospital of PLA and the Chinese Academy of Sciences. His experience in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Zegui Cai has collaborated with notable colleagues, including Bixue Xu and Guangyi Liang. These partnerships have further enriched his research and development efforts in pharmaceutical innovations.
Conclusion
Zegui Cai's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in the treatment of viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile